M. Christella

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.

F. Rosendaal, J. Rosing, C. Doggen, 2005, Human reproduction.

Acquired resistance to activated protein C in breast cancer patients

M. Nijziel, R. van Oerle, E. V. van Pampus, 2003, British journal of haematology.

Effect of oral contraceptives on the anticoagulant activity of protein S in plasma

R. Koenen, J. Rosing, T. Hackeng, 2005, Thrombosis and Haemostasis.

activated protein C-catalyzed factor Va-inactivation Re-evaluation of the role of the protein S-C4b binding protein complex in

B. Dahlbäck, G. Nicolaes, J. Rosing, 2013 .

Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous Thrombosis: A Randomized, Placebo-Controlled Study in Postmenopausal Women

C. Stehouwer, P. Kenemans, J. Rosing, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Effects of (Pre-)analytical Variables on Activated Protein C Resistance Determined Via a Thrombin Generation-based Assay

F. Rosendaal, R. Bertina, J. Rosing, 2002, Thrombosis and Haemostasis.

A Prothrombinase-based Assay for Detection of Resistance to Activated Protein C

H. Hemker, G. Nicolaes, R. van Oerle, 1996, Thrombosis and Haemostasis.